Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali(®)) Versus Etanercept (Enbrel(®)) - Findings from a Nurse Survey in Europe

INTRODUCTION: Enbrel(®) (etanercept: manufactured by Immunex Corporation, Newbury Park, Thousand Oaks, CA 91320, USA) was the first biological disease-modifying anti-rheumatic drug approved for the treatment of rheumatoid arthritis (RA) in Europe. More recently, an etanercept biosimilar (Benepali(®)...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Rheumatol Ther
Hoofdauteurs: Thakur, Kunal, Biberger, Anna, Handrich, Alexandra, Rezk, Mourad Farouk
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Healthcare 2016
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4999586/
https://ncbi.nlm.nih.gov/pubmed/27747519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-016-0035-1
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items